In yesterday’s Wall Street session, JanOne Inc (NASDAQ:JAN) shares traded at $0.53, up 64.75% from the previous session.
1 analysts cover JanOne Inc (NASDAQ:JAN), according to research data. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $20.00 and a low of $20.00, we find $20.00. Given the previous closing price of $0.32, this indicates a potential upside of 6150.0 percent. JAN stock price is now 34.70% away from the 50-day moving average and -44.25% away from the 200-day moving average. The market capitalization of the company currently stands at $2.22M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
The stock has received a hold rating from 1 analysts and a buy rating from 0. Brokers who have rated the stock have averaged $20.00 as their price target over the next twelve months.
A total of 18.89% of the company’s stock is owned by insiders.
On Thursday morning JanOne Inc (NASDAQ: JAN) stock kicked off with the opening price of $0.4000. During the past 12 months, JanOne Inc has had a low of $0.22 and a high of $2.23. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 0.10, and a quick ratio of 0.10. The fifty day moving average price for JAN is $0.3944 and a two-hundred day moving average price translates $0.9526 for the stock.
The latest earnings results from JanOne Inc (NASDAQ: JAN) was released for Jun, 2023. The net profit margin was -80.17% and return on equity was -59.44% for JAN.
JanOne Inc(JAN) Company Profile
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through Biotechnology and Recycling segments. The company’s lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
